nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP2B6—malignant glioma	0.637	1	CbGaD
Azelastine—CYP1A2—Carmustine—malignant glioma	0.0947	0.57	CbGbCtD
Azelastine—CYP3A4—Temozolomide—malignant glioma	0.0716	0.431	CbGbCtD
Azelastine—Clozapine—CALY—malignant glioma	0.0023	0.6	CrCbGaD
Azelastine—Parosmia—Temozolomide—malignant glioma	0.00211	0.0333	CcSEcCtD
Azelastine—Influenza-like symptoms—Temozolomide—malignant glioma	0.00192	0.0302	CcSEcCtD
Azelastine—Breast pain—Temozolomide—malignant glioma	0.00157	0.0247	CcSEcCtD
Azelastine—Amenorrhoea—Temozolomide—malignant glioma	0.00156	0.0245	CcSEcCtD
Azelastine—Thinking abnormal—Carmustine—malignant glioma	0.00155	0.0244	CcSEcCtD
Azelastine—Viral infection—Temozolomide—malignant glioma	0.00152	0.0239	CcSEcCtD
Azelastine—Herpes simplex—Temozolomide—malignant glioma	0.00149	0.0234	CcSEcCtD
Azelastine—Influenza like illness—Temozolomide—malignant glioma	0.00133	0.0209	CcSEcCtD
Azelastine—Abnormal vision—Carmustine—malignant glioma	0.00124	0.0195	CcSEcCtD
Azelastine—Mental disability—Carmustine—malignant glioma	0.00123	0.0194	CcSEcCtD
Azelastine—Abnormal vision—Temozolomide—malignant glioma	0.00119	0.0188	CcSEcCtD
Azelastine—Mental disability—Temozolomide—malignant glioma	0.00119	0.0187	CcSEcCtD
Azelastine—Eye pain—Carmustine—malignant glioma	0.00114	0.0179	CcSEcCtD
Azelastine—Mazindol—SLC6A3—malignant glioma	0.00113	0.294	CrCbGaD
Azelastine—Gastroenteritis—Temozolomide—malignant glioma	0.00112	0.0177	CcSEcCtD
Azelastine—Eye pain—Temozolomide—malignant glioma	0.0011	0.0173	CcSEcCtD
Azelastine—Face oedema—Carmustine—malignant glioma	0.000993	0.0156	CcSEcCtD
Azelastine—Face oedema—Temozolomide—malignant glioma	0.00096	0.0151	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000877	0.0138	CcSEcCtD
Azelastine—Bronchitis—Temozolomide—malignant glioma	0.000827	0.013	CcSEcCtD
Azelastine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000799	0.0126	CcSEcCtD
Azelastine—Pollakiuria—Temozolomide—malignant glioma	0.000794	0.0125	CcSEcCtD
Azelastine—Weight increased—Temozolomide—malignant glioma	0.000782	0.0123	CcSEcCtD
Azelastine—Sinusitis—Temozolomide—malignant glioma	0.000719	0.0113	CcSEcCtD
Azelastine—Hypoaesthesia—Carmustine—malignant glioma	0.000708	0.0112	CcSEcCtD
Azelastine—Visual impairment—Carmustine—malignant glioma	0.000686	0.0108	CcSEcCtD
Azelastine—Hypoaesthesia—Temozolomide—malignant glioma	0.000684	0.0108	CcSEcCtD
Azelastine—Pharyngitis—Temozolomide—malignant glioma	0.000683	0.0108	CcSEcCtD
Azelastine—Eye disorder—Carmustine—malignant glioma	0.000665	0.0105	CcSEcCtD
Azelastine—Visual impairment—Temozolomide—malignant glioma	0.000663	0.0104	CcSEcCtD
Azelastine—Flushing—Carmustine—malignant glioma	0.000661	0.0104	CcSEcCtD
Azelastine—Eye disorder—Temozolomide—malignant glioma	0.000643	0.0101	CcSEcCtD
Azelastine—Flushing—Temozolomide—malignant glioma	0.000638	0.0101	CcSEcCtD
Azelastine—Back pain—Carmustine—malignant glioma	0.000599	0.00944	CcSEcCtD
Azelastine—Dysgeusia—Temozolomide—malignant glioma	0.000586	0.00923	CcSEcCtD
Azelastine—Vision blurred—Carmustine—malignant glioma	0.000584	0.0092	CcSEcCtD
Azelastine—HRH3—brainstem—malignant glioma	0.00058	0.113	CbGeAlD
Azelastine—Back pain—Temozolomide—malignant glioma	0.000579	0.00912	CcSEcCtD
Azelastine—Agitation—Carmustine—malignant glioma	0.000569	0.00897	CcSEcCtD
Azelastine—Vision blurred—Temozolomide—malignant glioma	0.000564	0.00889	CcSEcCtD
Azelastine—Ill-defined disorder—Temozolomide—malignant glioma	0.000556	0.00875	CcSEcCtD
Azelastine—Agitation—Temozolomide—malignant glioma	0.00055	0.00867	CcSEcCtD
Azelastine—Malaise—Temozolomide—malignant glioma	0.00054	0.0085	CcSEcCtD
Azelastine—Vertigo—Temozolomide—malignant glioma	0.000538	0.00847	CcSEcCtD
Azelastine—Hypertension—Carmustine—malignant glioma	0.000535	0.00842	CcSEcCtD
Azelastine—Palpitations—Temozolomide—malignant glioma	0.000529	0.00833	CcSEcCtD
Azelastine—Chest pain—Carmustine—malignant glioma	0.000528	0.00831	CcSEcCtD
Azelastine—Myalgia—Carmustine—malignant glioma	0.000528	0.00831	CcSEcCtD
Azelastine—Anxiety—Carmustine—malignant glioma	0.000526	0.00828	CcSEcCtD
Azelastine—Cough—Temozolomide—malignant glioma	0.000523	0.00823	CcSEcCtD
Azelastine—Hypertension—Temozolomide—malignant glioma	0.000517	0.00814	CcSEcCtD
Azelastine—HRH3—telencephalon—malignant glioma	0.000515	0.1	CbGeAlD
Azelastine—Confusional state—Carmustine—malignant glioma	0.00051	0.00803	CcSEcCtD
Azelastine—Myalgia—Temozolomide—malignant glioma	0.00051	0.00803	CcSEcCtD
Azelastine—Anxiety—Temozolomide—malignant glioma	0.000508	0.008	CcSEcCtD
Azelastine—Discomfort—Temozolomide—malignant glioma	0.000504	0.00793	CcSEcCtD
Azelastine—Infection—Carmustine—malignant glioma	0.000502	0.00791	CcSEcCtD
Azelastine—Dry mouth—Temozolomide—malignant glioma	0.000499	0.00785	CcSEcCtD
Azelastine—Tachycardia—Carmustine—malignant glioma	0.000494	0.00777	CcSEcCtD
Azelastine—Confusional state—Temozolomide—malignant glioma	0.000493	0.00776	CcSEcCtD
Azelastine—Anaphylactic shock—Temozolomide—malignant glioma	0.000489	0.0077	CcSEcCtD
Azelastine—Infection—Temozolomide—malignant glioma	0.000486	0.00765	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000461	0.00726	CcSEcCtD
Azelastine—Paraesthesia—Carmustine—malignant glioma	0.000454	0.00715	CcSEcCtD
Azelastine—Dyspnoea—Carmustine—malignant glioma	0.000451	0.0071	CcSEcCtD
Azelastine—Somnolence—Carmustine—malignant glioma	0.00045	0.00708	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000445	0.00701	CcSEcCtD
Azelastine—Paraesthesia—Temozolomide—malignant glioma	0.000439	0.00691	CcSEcCtD
Azelastine—Dyspnoea—Temozolomide—malignant glioma	0.000436	0.00686	CcSEcCtD
Azelastine—Somnolence—Temozolomide—malignant glioma	0.000434	0.00684	CcSEcCtD
Azelastine—Pain—Carmustine—malignant glioma	0.000432	0.00681	CcSEcCtD
Azelastine—Constipation—Carmustine—malignant glioma	0.000432	0.00681	CcSEcCtD
Azelastine—Fatigue—Temozolomide—malignant glioma	0.000421	0.00663	CcSEcCtD
Azelastine—Pain—Temozolomide—malignant glioma	0.000418	0.00658	CcSEcCtD
Azelastine—Constipation—Temozolomide—malignant glioma	0.000418	0.00658	CcSEcCtD
Azelastine—Feeling abnormal—Carmustine—malignant glioma	0.000417	0.00656	CcSEcCtD
Azelastine—Gastrointestinal pain—Carmustine—malignant glioma	0.000414	0.00651	CcSEcCtD
Azelastine—Loxapine—SLC6A3—malignant glioma	0.000408	0.106	CrCbGaD
Azelastine—Feeling abnormal—Temozolomide—malignant glioma	0.000403	0.00634	CcSEcCtD
Azelastine—Abdominal pain—Carmustine—malignant glioma	0.0004	0.0063	CcSEcCtD
Azelastine—Body temperature increased—Carmustine—malignant glioma	0.0004	0.0063	CcSEcCtD
Azelastine—Gastrointestinal pain—Temozolomide—malignant glioma	0.0004	0.00629	CcSEcCtD
Azelastine—Body temperature increased—Temozolomide—malignant glioma	0.000386	0.00608	CcSEcCtD
Azelastine—Abdominal pain—Temozolomide—malignant glioma	0.000386	0.00608	CcSEcCtD
Azelastine—Hypersensitivity—Carmustine—malignant glioma	0.000373	0.00587	CcSEcCtD
Azelastine—Asthenia—Carmustine—malignant glioma	0.000363	0.00571	CcSEcCtD
Azelastine—Hypersensitivity—Temozolomide—malignant glioma	0.00036	0.00567	CcSEcCtD
Azelastine—Asthenia—Temozolomide—malignant glioma	0.000351	0.00552	CcSEcCtD
Azelastine—Diarrhoea—Carmustine—malignant glioma	0.000346	0.00545	CcSEcCtD
Azelastine—Pruritus—Temozolomide—malignant glioma	0.000346	0.00544	CcSEcCtD
Azelastine—Dizziness—Carmustine—malignant glioma	0.000334	0.00527	CcSEcCtD
Azelastine—Diarrhoea—Temozolomide—malignant glioma	0.000334	0.00527	CcSEcCtD
Azelastine—Dizziness—Temozolomide—malignant glioma	0.000323	0.00509	CcSEcCtD
Azelastine—Vomiting—Carmustine—malignant glioma	0.000322	0.00506	CcSEcCtD
Azelastine—Rash—Carmustine—malignant glioma	0.000319	0.00502	CcSEcCtD
Azelastine—Dermatitis—Carmustine—malignant glioma	0.000319	0.00502	CcSEcCtD
Azelastine—Headache—Carmustine—malignant glioma	0.000317	0.00499	CcSEcCtD
Azelastine—Vomiting—Temozolomide—malignant glioma	0.000311	0.00489	CcSEcCtD
Azelastine—Rash—Temozolomide—malignant glioma	0.000308	0.00485	CcSEcCtD
Azelastine—Dermatitis—Temozolomide—malignant glioma	0.000308	0.00485	CcSEcCtD
Azelastine—Headache—Temozolomide—malignant glioma	0.000306	0.00482	CcSEcCtD
Azelastine—Nausea—Carmustine—malignant glioma	0.0003	0.00473	CcSEcCtD
Azelastine—HRH3—central nervous system—malignant glioma	0.000293	0.0569	CbGeAlD
Azelastine—Nausea—Temozolomide—malignant glioma	0.00029	0.00457	CcSEcCtD
Azelastine—HRH3—cerebellum—malignant glioma	0.000286	0.0556	CbGeAlD
Azelastine—HRH3—brain—malignant glioma	0.000232	0.0451	CbGeAlD
Azelastine—ADRA1B—central nervous system—malignant glioma	0.000156	0.0303	CbGeAlD
Azelastine—KCNH2—telencephalon—malignant glioma	0.000149	0.0289	CbGeAlD
Azelastine—CYP2A6—cerebellum—malignant glioma	0.000135	0.0262	CbGeAlD
Azelastine—ABCB1—blood vessel—malignant glioma	0.000134	0.0261	CbGeAlD
Azelastine—ADRA1B—brain—malignant glioma	0.000124	0.024	CbGeAlD
Azelastine—HRH1—telencephalon—malignant glioma	0.000119	0.0232	CbGeAlD
Azelastine—KCNH2—medulla oblongata—malignant glioma	0.000117	0.0227	CbGeAlD
Azelastine—CYP2E1—telencephalon—malignant glioma	0.000115	0.0223	CbGeAlD
Azelastine—CYP2A6—brain—malignant glioma	0.000109	0.0213	CbGeAlD
Azelastine—KCNH2—midbrain—malignant glioma	0.000107	0.0208	CbGeAlD
Azelastine—KCNH2—spinal cord—malignant glioma	0.000104	0.0203	CbGeAlD
Azelastine—CYP2D6—brainstem—malignant glioma	0.000102	0.0199	CbGeAlD
Azelastine—CYP2D6—telencephalon—malignant glioma	9.07e-05	0.0176	CbGeAlD
Azelastine—CYP2E1—medulla oblongata—malignant glioma	9e-05	0.0175	CbGeAlD
Azelastine—KCNH2—central nervous system—malignant glioma	8.45e-05	0.0164	CbGeAlD
Azelastine—KCNH2—cerebellum—malignant glioma	8.26e-05	0.0161	CbGeAlD
Azelastine—CYP2E1—spinal cord—malignant glioma	8.03e-05	0.0156	CbGeAlD
Azelastine—ABCB1—embryo—malignant glioma	8.02e-05	0.0156	CbGeAlD
Azelastine—CYP1A1—central nervous system—malignant glioma	7.14e-05	0.0139	CbGeAlD
Azelastine—ABCB1—retina—malignant glioma	7.09e-05	0.0138	CbGeAlD
Azelastine—CYP2B6—central nervous system—malignant glioma	6.94e-05	0.0135	CbGeAlD
Azelastine—HRH1—central nervous system—malignant glioma	6.78e-05	0.0132	CbGeAlD
Azelastine—KCNH2—brain—malignant glioma	6.71e-05	0.013	CbGeAlD
Azelastine—ABCB1—telencephalon—malignant glioma	6.52e-05	0.0127	CbGeAlD
Azelastine—CYP2E1—central nervous system—malignant glioma	6.51e-05	0.0127	CbGeAlD
Azelastine—CYP2E1—cerebellum—malignant glioma	6.36e-05	0.0124	CbGeAlD
Azelastine—CYP2C8—brain—malignant glioma	6.14e-05	0.0119	CbGeAlD
Azelastine—CYP1A1—brain—malignant glioma	5.67e-05	0.011	CbGeAlD
Azelastine—CYP2B6—brain—malignant glioma	5.51e-05	0.0107	CbGeAlD
Azelastine—HRH1—brain—malignant glioma	5.38e-05	0.0105	CbGeAlD
Azelastine—CYP3A4—central nervous system—malignant glioma	5.24e-05	0.0102	CbGeAlD
Azelastine—CYP2E1—brain—malignant glioma	5.17e-05	0.01	CbGeAlD
Azelastine—CYP2D6—central nervous system—malignant glioma	5.15e-05	0.01	CbGeAlD
Azelastine—ABCB1—medulla oblongata—malignant glioma	5.13e-05	0.00996	CbGeAlD
Azelastine—CYP2D6—cerebellum—malignant glioma	5.04e-05	0.00979	CbGeAlD
Azelastine—ABCB1—midbrain—malignant glioma	4.69e-05	0.0091	CbGeAlD
Azelastine—ABCB1—spinal cord—malignant glioma	4.57e-05	0.00888	CbGeAlD
Azelastine—CYP2D6—brain—malignant glioma	4.09e-05	0.00795	CbGeAlD
Azelastine—ABCB1—central nervous system—malignant glioma	3.71e-05	0.00721	CbGeAlD
Azelastine—ABCB1—cerebellum—malignant glioma	3.62e-05	0.00704	CbGeAlD
Azelastine—ABCB1—brain—malignant glioma	2.94e-05	0.00572	CbGeAlD
Azelastine—ADRA1B—Signaling Pathways—TERT—malignant glioma	1.04e-05	8.42e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—BCHE—malignant glioma	1.04e-05	8.41e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.04e-05	8.38e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—BCHE—malignant glioma	1.03e-05	8.33e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—PIK3CB—malignant glioma	1.03e-05	8.33e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.03e-05	8.3e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PDGFRA—malignant glioma	1.03e-05	8.28e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.02e-05	8.27e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.02e-05	8.23e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—IDH1—malignant glioma	1.02e-05	8.23e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PDGFB—malignant glioma	1.02e-05	8.22e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—FGFR1—malignant glioma	1.01e-05	8.18e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTT1—malignant glioma	1.01e-05	8.17e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—NCOR1—malignant glioma	1.01e-05	8.17e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GSTP1—malignant glioma	1.01e-05	8.15e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PIK3CG—malignant glioma	1.01e-05	8.14e-05	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1e-05	8.12e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HIF1A—malignant glioma	9.97e-06	8.05e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SPP1—malignant glioma	9.96e-06	8.04e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CXCL8—malignant glioma	9.91e-06	8.01e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SPHK1—malignant glioma	9.86e-06	7.96e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CAT—malignant glioma	9.81e-06	7.93e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PPARG—malignant glioma	9.72e-06	7.85e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP2C18—malignant glioma	9.66e-06	7.8e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CAV1—malignant glioma	9.64e-06	7.79e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.64e-06	7.78e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.55e-06	7.71e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—KDR—malignant glioma	9.54e-06	7.7e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTGS1—malignant glioma	9.48e-06	7.66e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL2—malignant glioma	9.47e-06	7.65e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.45e-06	7.63e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TERT—malignant glioma	9.44e-06	7.62e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—NCOR1—malignant glioma	9.27e-06	7.49e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PDGFB—malignant glioma	9.21e-06	7.44e-05	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—AKT1—malignant glioma	9.19e-06	7.42e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—FN1—malignant glioma	9.18e-06	7.42e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—F2—malignant glioma	9.18e-06	7.42e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—FGFR1—malignant glioma	9.16e-06	7.4e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.13e-06	7.38e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—BAD—malignant glioma	9.07e-06	7.33e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HIF1A—malignant glioma	9.03e-06	7.29e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GSTP1—malignant glioma	9e-06	7.27e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NOTCH1—malignant glioma	8.98e-06	7.26e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CAV1—malignant glioma	8.92e-06	7.21e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PIK3CD—malignant glioma	8.86e-06	7.15e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—BCHE—malignant glioma	8.82e-06	7.12e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CD80—malignant glioma	8.8e-06	7.11e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GSTP1—malignant glioma	8.79e-06	7.1e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—APC—malignant glioma	8.78e-06	7.1e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3CG—malignant glioma	8.78e-06	7.1e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CAT—malignant glioma	8.76e-06	7.08e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CAV1—malignant glioma	8.74e-06	7.06e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CAV1—malignant glioma	8.73e-06	7.05e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CAV1—malignant glioma	8.72e-06	7.05e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—SLC5A5—malignant glioma	8.71e-06	7.03e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EGF—malignant glioma	8.68e-06	7.01e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—KDR—malignant glioma	8.63e-06	6.97e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PTPN11—malignant glioma	8.63e-06	6.97e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CAT—malignant glioma	8.55e-06	6.91e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.33e-06	6.73e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—F2—malignant glioma	8.31e-06	6.71e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—FN1—malignant glioma	8.31e-06	6.71e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GSTP1—malignant glioma	8.28e-06	6.69e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—NCOR1—malignant glioma	8.27e-06	6.68e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—BRAF—malignant glioma	8.26e-06	6.67e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CAV1—malignant glioma	8.24e-06	6.66e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.24e-06	6.65e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—BAD—malignant glioma	8.21e-06	6.63e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GSTP1—malignant glioma	8.21e-06	6.63e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.16e-06	6.59e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NOTCH1—malignant glioma	8.13e-06	6.57e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CG—malignant glioma	8.13e-06	6.57e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—NCOR1—malignant glioma	8.07e-06	6.52e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CAT—malignant glioma	8.06e-06	6.51e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AKT2—malignant glioma	8.04e-06	6.49e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—EGFR—malignant glioma	8e-06	6.47e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CAT—malignant glioma	7.99e-06	6.45e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CD80—malignant glioma	7.97e-06	6.44e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CG—malignant glioma	7.96e-06	6.43e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CG—malignant glioma	7.95e-06	6.42e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—APC—malignant glioma	7.95e-06	6.42e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CG—malignant glioma	7.95e-06	6.42e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.87e-06	6.36e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EGF—malignant glioma	7.86e-06	6.35e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PPARG—malignant glioma	7.85e-06	6.34e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PTPN11—malignant glioma	7.81e-06	6.31e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTT1—malignant glioma	7.81e-06	6.31e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3CD—malignant glioma	7.72e-06	6.24e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PIK3CB—malignant glioma	7.72e-06	6.24e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PPARG—malignant glioma	7.68e-06	6.21e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PPARG—malignant glioma	7.67e-06	6.19e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTGS2—malignant glioma	7.65e-06	6.18e-05	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—PIK3CA—malignant glioma	7.65e-06	6.18e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—NCOR1—malignant glioma	7.61e-06	6.15e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—KRAS—malignant glioma	7.56e-06	6.11e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CAV1—malignant glioma	7.56e-06	6.1e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—NCOR1—malignant glioma	7.54e-06	6.09e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CG—malignant glioma	7.51e-06	6.06e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—BRAF—malignant glioma	7.47e-06	6.04e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—FGF2—malignant glioma	7.39e-06	5.97e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTGS1—malignant glioma	7.32e-06	5.91e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AKT2—malignant glioma	7.28e-06	5.88e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PPARG—malignant glioma	7.25e-06	5.85e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—EGFR—malignant glioma	7.24e-06	5.85e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.22e-06	5.83e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CD—malignant glioma	7.15e-06	5.77e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.12e-06	5.75e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTP1—malignant glioma	7.01e-06	5.67e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CD—malignant glioma	7e-06	5.65e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CD—malignant glioma	6.99e-06	5.65e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CD—malignant glioma	6.99e-06	5.64e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—PIK3CA—malignant glioma	6.95e-06	5.61e-05	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	6.92e-06	5.59e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MDM2—malignant glioma	6.92e-06	5.59e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—RAF1—malignant glioma	6.89e-06	5.57e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CG—malignant glioma	6.88e-06	5.56e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—KRAS—malignant glioma	6.84e-06	5.53e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CAT—malignant glioma	6.83e-06	5.51e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ERBB2—malignant glioma	6.82e-06	5.51e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—BCHE—malignant glioma	6.8e-06	5.5e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CAV1—malignant glioma	6.74e-06	5.45e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	6.73e-06	5.44e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.72e-06	5.43e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—FGF2—malignant glioma	6.69e-06	5.41e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTEN—malignant glioma	6.67e-06	5.39e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PPARG—malignant glioma	6.64e-06	5.37e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CD—malignant glioma	6.6e-06	5.33e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CAV1—malignant glioma	6.58e-06	5.32e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	6.47e-06	5.23e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—NCOR1—malignant glioma	6.45e-06	5.21e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.44e-06	5.2e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	6.29e-06	5.08e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MDM2—malignant glioma	6.26e-06	5.06e-05	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	6.25e-06	5.05e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—RAF1—malignant glioma	6.24e-06	5.04e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CB—malignant glioma	6.23e-06	5.03e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CAV1—malignant glioma	6.2e-06	5.01e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CASP3—malignant glioma	6.19e-06	5e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL2—malignant glioma	6.18e-06	4.99e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ERBB2—malignant glioma	6.17e-06	4.99e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTGS2—malignant glioma	6.17e-06	4.99e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CAV1—malignant glioma	6.15e-06	4.97e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CG—malignant glioma	6.14e-06	4.96e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CB—malignant glioma	6.1e-06	4.93e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	6.09e-06	4.92e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CB—malignant glioma	6.09e-06	4.92e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CD—malignant glioma	6.05e-06	4.89e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTGS2—malignant glioma	6.05e-06	4.88e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTGS2—malignant glioma	6.03e-06	4.87e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CG—malignant glioma	6e-06	4.84e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PPARG—malignant glioma	5.93e-06	4.79e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.87e-06	4.75e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CXCL8—malignant glioma	5.86e-06	4.73e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MMP9—malignant glioma	5.85e-06	4.73e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PTEN—malignant glioma	5.82e-06	4.7e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PPARG—malignant glioma	5.79e-06	4.67e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CB—malignant glioma	5.75e-06	4.65e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTGS2—malignant glioma	5.7e-06	4.6e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	5.67e-06	4.58e-05	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	5.66e-06	4.57e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.65e-06	4.56e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CASP3—malignant glioma	5.6e-06	4.53e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CG—malignant glioma	5.6e-06	4.52e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL2—malignant glioma	5.6e-06	4.52e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PPARG—malignant glioma	5.45e-06	4.4e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTP1—malignant glioma	5.41e-06	4.37e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PPARG—malignant glioma	5.41e-06	4.37e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CD—malignant glioma	5.4e-06	4.36e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTEN—malignant glioma	5.38e-06	4.35e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MMP9—malignant glioma	5.3e-06	4.28e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CB—malignant glioma	5.27e-06	4.26e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTEN—malignant glioma	5.27e-06	4.26e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CD—malignant glioma	5.27e-06	4.26e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CAT—malignant glioma	5.27e-06	4.26e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PTEN—malignant glioma	5.27e-06	4.25e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTEN—malignant glioma	5.26e-06	4.25e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CAV1—malignant glioma	5.25e-06	4.24e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	5.25e-06	4.24e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTGS2—malignant glioma	5.23e-06	4.22e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—STAT3—malignant glioma	5.2e-06	4.2e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—AKT1—malignant glioma	5.14e-06	4.15e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.02e-06	4.06e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NCOR1—malignant glioma	4.97e-06	4.02e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTEN—malignant glioma	4.97e-06	4.01e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.97e-06	4.01e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.92e-06	3.98e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MYC—malignant glioma	4.83e-06	3.9e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CG—malignant glioma	4.79e-06	3.87e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VEGFA—malignant glioma	4.76e-06	3.84e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EGFR—malignant glioma	4.73e-06	3.82e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—STAT3—malignant glioma	4.71e-06	3.8e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.71e-06	3.8e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PIK3CA—malignant glioma	4.71e-06	3.8e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTGS2—malignant glioma	4.66e-06	3.77e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PPARG—malignant glioma	4.62e-06	3.73e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CB—malignant glioma	4.59e-06	3.71e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTEN—malignant glioma	4.56e-06	3.68e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTGS2—malignant glioma	4.55e-06	3.68e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—KRAS—malignant glioma	4.47e-06	3.61e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MYC—malignant glioma	4.38e-06	3.53e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.33e-06	3.5e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.29e-06	3.47e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTGS2—malignant glioma	4.29e-06	3.47e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EGFR—malignant glioma	4.28e-06	3.46e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTGS2—malignant glioma	4.25e-06	3.44e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CD—malignant glioma	4.21e-06	3.4e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	4.1e-06	3.31e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTEN—malignant glioma	4.07e-06	3.29e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CAV1—malignant glioma	4.06e-06	3.28e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—KRAS—malignant glioma	4.04e-06	3.27e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTEN—malignant glioma	3.97e-06	3.21e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TP53—malignant glioma	3.97e-06	3.21e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—AKT1—malignant glioma	3.84e-06	3.11e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.8e-06	3.07e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTEN—malignant glioma	3.74e-06	3.02e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CA—malignant glioma	3.72e-06	3e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	3.71e-06	3e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CA—malignant glioma	3.71e-06	3e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTEN—malignant glioma	3.71e-06	3e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.69e-06	2.98e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.67e-06	2.96e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTGS2—malignant glioma	3.63e-06	2.94e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TP53—malignant glioma	3.59e-06	2.9e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PPARG—malignant glioma	3.57e-06	2.88e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CA—malignant glioma	3.51e-06	2.83e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AKT1—malignant glioma	3.35e-06	2.71e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.25e-06	2.62e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CA—malignant glioma	3.21e-06	2.6e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTEN—malignant glioma	3.17e-06	2.56e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—AKT1—malignant glioma	3.1e-06	2.51e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—AKT1—malignant glioma	3.04e-06	2.45e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AKT1—malignant glioma	3.03e-06	2.45e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—AKT1—malignant glioma	3.03e-06	2.45e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.87e-06	2.32e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—AKT1—malignant glioma	2.86e-06	2.31e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.83e-06	2.29e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.8e-06	2.27e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CA—malignant glioma	2.8e-06	2.26e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.64e-06	2.13e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AKT1—malignant glioma	2.63e-06	2.12e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.62e-06	2.11e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTEN—malignant glioma	2.45e-06	1.98e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AKT1—malignant glioma	2.34e-06	1.89e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AKT1—malignant glioma	2.29e-06	1.85e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.24e-06	1.81e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AKT1—malignant glioma	2.16e-06	1.74e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AKT1—malignant glioma	2.14e-06	1.73e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKT1—malignant glioma	1.83e-06	1.48e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.73e-06	1.39e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKT1—malignant glioma	1.41e-06	1.14e-05	CbGpPWpGaD
